Figure 1.

Cancer-specific survival (Kaplan-Meier) for all UUT-UC patients plotted against the pre-operative CRP-group. The 5-year survival rates were 54.2 and 26.4%, respectively, for all evaluable patients (n=77) with a CRP of ≤5 mg/l (n=36) and >5 mg/l (n=41), respectively (p=0.006, log rank).

Stein et al. BMC Cancer 2013 13:101   doi:10.1186/1471-2407-13-101
Download authors' original image